Zahra Ghasemi: The Human Reality of IVIG Access
Zahra Ghasemi, Pharmacoeconomist, Member of Health Technology Assessment international and Cochrane, shared a post on LinkedIn:
“Different diagnoses, one lifeline: The human reality of IVIG access!
Last year, I shared a deeply personal chapter of my life: my sister’s battle with Guillain-Barré Syndrome (GBS).
While that experience was a sudden, acute crisis, today marks the start of Primary Immunodeficiency Diseases International Awareness Week.
On the surface, these conditions seem worlds apart; one is a rare neurological attack, the other a lifelong immune deficiency, but they are bound together by a single, critical lifeline: IVIG.
Today, a global effort is shining a light on primary immunodeficiency, a group of over 400 rare, chronic disorders in which the body’s immune system is missing or functions improperly.
For millions of PID patients, IVIG is not just ‘medication’; it is their external immune system.
It is the bridge that allows a child to go to school or an adult to sustain a career.
Yet, because these therapies rely entirely on human plasma donation and complex fractionation, ‘access’ remains one of our greatest global health challenges.
Awareness is the first step toward policy change.
Whether we are industry professionals, policymakers, or citizens, we must advocate for a world in which ‘plasma, the liquid gold’ is accessible to every patient who relies on it to survive.”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?
-
Jun 23, 2026, 17:33Maité Mulkers: Time is Brain, and One Reason is That a Thrombus Develops Over Time
-
Jun 23, 2026, 17:32Dhargam Aljebouri: Honoured to Be Part of the Young Professionals Breakfast at ISBT 2026
-
Jun 23, 2026, 17:27Dianne E. van der Wal: Phenotype and Activation of the Endothelium in ET at ISTH 2026